Medicines Access

flowerhaus
Posted by flowerhaus
January 14, 2021

Is there a role for Ethics Committees in Pre-approval Access?

In discussions with our clients over recent months...

Read More
flowerhaus
Posted by flowerhaus
December 10, 2020

Inceptua Q&A: What is Pre-Approval Access?

“What is pre-approval and unlicensed access to medicines?”...

Read More
flowerhaus
Posted by flowerhaus
November 6, 2020

Pre-approval Access

Regulatory Update 2020 The regulations governing pre-approval access...

Read More
flowerhaus
Posted by flowerhaus
November 2, 2020

Maintaining access to your medicines during COVID19

As an agile, global, and robust provider of...

Read More
flowerhaus
Posted by flowerhaus
March 3, 2020
flowerhaus
Posted by flowerhaus
October 29, 2019
flowerhaus
Posted by flowerhaus
April 9, 2019

Expediting Access to Rare Disease Therapies in Europe

“Exploring Multi-Stakeholder Approaches” Globally there are approximately 7,000...

Read More
flowerhaus
Posted by flowerhaus
March 14, 2019

Providing Access to Unlicensed Medicines

“The Role of Pharmaceutical Manufacturers” What’s driving demand...

Read More
flowerhaus
Posted by flowerhaus
October 9, 2018
We use cookies to give you the best experience.